A citation-based method for searching scientific literature

H L Paulson, S S Das, P B Crino, M K Perez, S C Patel, D Gotsdiner, K H Fischbeck, R N Pittman. Ann Neurol 1997
Times Cited: 215



Hartmut Scheel, Stefan Tomiuk, Kay Hofmann. Hum Mol Genet 2003
Times Cited: 107




List of shared articles



Times cited

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Naila S Ashraf, Joanna R Sutton, Yemen Yang, Bedri Ranxhi, Kozeta Libohova, Emily D Shaw, Anna J Barget, Sokol V Todi, Henry L Paulson, Maria do Carmo Costa. Neurobiol Dis 2020
3


Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
37

Spinocerebellar ataxia type 1.
Stefano Di Donato, Caterina Mariotti, Franco Taroni. Handb Clin Neurol 2012
20

Machado-Joseph disease/spinocerebellar ataxia type 3.
Henry Paulson. Handb Clin Neurol 2012
77

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
154

Regulation of cellular responses by deubiquitinating enzymes: an update.
James F Burrows, James A Johnston. Front Biosci (Landmark Ed) 2012
13

Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease.
Ana T Simões, Nélio Gonçalves, Arnulf Koeppen, Nicole Déglon, Sebastian Kügler, Carlos Bandeira Duarte, Luís Pereira de Almeida. Brain 2012
77


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
88

Proteotoxic stress increases nuclear localization of ataxin-3.
Christopher P Reina, Xiaoyan Zhong, Randall N Pittman. Hum Mol Genet 2010
60

Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Sandro Alves, Isabel Nascimento-Ferreira, Noëlle Dufour, Raymonde Hassig, Gwennaëlle Auregan, Clévio Nóbrega, Emmanuel Brouillet, Philippe Hantraye, Maria C Pedroso de Lima, Nicole Déglon,[...]. Hum Mol Genet 2010
74

CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.
V Pastori, E Sangalli, P Coccetti, C Pozzi, S Nonnis, G Tedeschi, P Fusi. Biochim Biophys Acta 2010
15


Therapeutic prospects for spinocerebellar ataxia type 2 and 3.
Ilya Bezprozvanny, Thomas Klockgether. Drugs Future 2009
14

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.
Xi Chen, Tie-Shan Tang, Huiping Tu, Omar Nelson, Mark Pook, Robert Hammer, Nobuyuki Nukina, Ilya Bezprozvanny. J Neurosci 2008
151

Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.
Fernanda Ricchelli, Paola Fusi, Paolo Tortora, Marco Valtorta, Matteo Riva, Giuseppe Tognon, Katia Chieregato, Silvia Bolognin, Paolo Zatta. Int J Biochem Cell Biol 2007
14

p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
Hongfeng Wang, Nali Jia, Erkang Fei, Zhiming Wang, Chao Liu, Tao Zhang, Jun Fan, Mian Wu, Lin Chen, Nobuyuki Nukina,[...]. J Neurochem 2007
14